Skip to content

Neuronetics STIM Market capitalization

Market capitalization at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
$2.44B-4.8%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$707.12M
Stereotaxis logo
StereotaxisSTXS
$178.94M+18.2%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$442.72M+10.6%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$13.22B+19.9%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$269.94M-17.8%

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Enterprise value$162.64M-44.6%
P/S0.6×-1.4×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Computed from the period-end share price: $100.45M.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's market capitalization?
Neuronetics (STIM) reported market capitalization of $100.45M in Q1 2026.
How has Neuronetics's market capitalization changed year-over-year?
Neuronetics's market capitalization decreased by 57.9% year-over-year, from $238.76M to $100.45M.
What is the long-term trend for Neuronetics's market capitalization?
Over 5 years (2020 to 2025), Neuronetics's market capitalization has grown at a -20.2% compound annual growth rate (CAGR), from $292.95M to $94.51M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.